Inalways Corp is a Taiwan-based company mainly engaged in medical biotechnology and other businesses. The Company's main products include prescription drugs, indicated drugs, medical equipment, and food and health products. The Company also engages in health screening. The Company mainly operates in the Taiwan market.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
30/26/30	NT$16.35	-0.91%	74,167
29/26/29	NT$16.50	-0.90%	44,124
28/26/28	NT$16.65	-2.06%	96,355
27/26/27	NT$17.00	+0.89%	1,41,900
22/26/22	NT$16.85	-4.53%	3,60,622

End-of-day quote Taipei Exchange

More quotes

End-of-day quote Taipei Exchange 30/10/2026			5-day change	1st Jan Change
16.35 ^TWD	-0.91%		-2.97%	-37.12%

13/08	Mediera Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
14/05	Mediera Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	81Cr 2.48Cr 2.22Cr 2.04Cr 1.85Cr 3.46Cr 235.34Cr 3.52Cr 24Cr 9.77Cr 123.8Cr 9.3Cr 9.1Cr 390.41Cr	P/E 2024	92.6x	P/E 2025	74.3x
Enterprise Value	71Cr 2.18Cr 1.95Cr 1.79Cr 1.62Cr 3.03Cr 206.53Cr 3.09Cr 21Cr 8.58Cr 108.64Cr 8.16Cr 7.99Cr 342.61Cr	EV / Sales 2024	3.69x	EV / Sales 2025	5.16x
Free-Float	53.64%	Yield 2024 *	-	Yield 2025	-

13/08	Mediera Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
14/05	Mediera Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
06/03	Mediera Corporation Reports Earnings Results for the Full Year Ended December 31, 2025	CI
14/11	Mediera Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11/25/11	Mediera Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
05/25/05	Mediera Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
26/25/26	Mediera Corporation Reports Earnings Results for the Full Year Ended December 31, 2024	CI
13/24/13	Mediera Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
14/24/14	Mediera Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
15/24/15	Mediera Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
06/24/06	Mediera Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
11/23/11	Mediera Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
11/23/11	Mediera Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

1 day	-0.91%
1 week	-2.97%
Current month	+18.05%
1 month	+18.05%
3 months	+12.76%
6 months	-19.06%
Current year	-37.12%

Mediera Corporation Share Price

Stocks

5398

TW0005398002

Biotechnology & Medical Research

Valuation: Mediera Corporation

Chart: Mediera Corporation

Latest news: Mediera Corporation

Quotes and Performance

Price Extremes

Managers and Directors: Mediera Corporation

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

1 week	16.1	17.85
1 month	13.6	18.9
Current year	13.6	26.15
1 year	13.6	31
3 years	11	31
5 years	11	31
10 years	11	48.5

Manager	Title	Age	Since
Hsu Jen Huang CEO	Chief Executive Officer	-	28/06/2017
Hung Qin Peng DFI	Director of Finance/CFO	-	01/07/2016

Director	Title	Age	Since
Hsu Jen Huang CHM	Chairman	-	10/08/2019
Pin Yi Wu BRD	Director/Board Member	-	-
Te Lun Tang BRD	Director/Board Member	-	02/03/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MEDIERA CORPORATION	-0.91%	-2.97%	-12.57%	+47.96%	2.48Cr
WUXI APPTEC CO., LTD.	-0.62%	-1.87%	+46.31%	+56.99%	6.38TCr
ARGENX SE	+0.35%	+3.20%	+14.92%	+84.55%	5.64TCr
LONZA GROUP AG	+0.53%	+1.96%	+15.37%	+106.81%	5.46TCr
IQVIA HOLDINGS INC.	-2.81%	-4.31%	+23.50%	+50.90%	4.41TCr
BEONE MEDICINES AG	-0.33%	-1.93%	+20.15%	+98.45%	4.21TCr
REVOLUTION MEDICINES, INC.	+0.55%	+2.31%	+224.97%	+942.56%	4.1TCr
GENMAB A/S	+3.27%	+47.96%	+112.67%	+96.48%	3.49TCr
CELLTRION, INC.	+1.22%	-1.44%	+14.89%	+47.15%	3.28TCr
INSMED INCORPORATED	+0.89%	+20.55%	-42.03%	+373.03%	2.47TCr
Average	+0.21%	+6.49%	+41.82%	+190.49%	3.94TCr
Weighted average by Cap.	+0.18%	+5.44%	+48.50%	+186.12%

	2024	2025
Net sales	24Cr 73.09L 65.46L 60.21L 54.56L 1.02Cr 69Cr 1.04Cr 7.18Cr 2.88Cr 37Cr 2.74Cr 2.68Cr 115.12Cr	23Cr 70.44L 63.09L 58.03L 52.58L 98.28L 67Cr 1Cr 6.92Cr 2.78Cr 35Cr 2.64Cr 2.59Cr 110.95Cr
Net income	1.04Cr 3L 3L 3L 2L 4L 3.04Cr 5L 31.42L 12.61L 1.6Cr 12L 11.75L 5.04Cr	1.74Cr 5L 5L 4L 4L 7L 5.05Cr 8L 52.26L 20.98L 2.66Cr 19.96L 19.54L 8.38Cr
Net Debt	-8.31Cr -25.47L -22.81L -20.98L -19.01L -35.53L -24Cr -36.2L -2.5Cr -1Cr -13Cr -95.57L -93.54L -40Cr	-9.9Cr -30.34L -27.17L -25L -22.65L -42.34L -29Cr -43.13L -2.98Cr -1.2Cr -15Cr -1.14Cr -1.11Cr -48Cr